Sep 2, 2026 09:38PM
Aug 31, 2026 01:10PM
Aug 28, 2026 05:48PM
Aug 26, 2026 09:38PM
Aug 24, 2026 12:16PM
Aug 24, 2026 09:25AM
Aug 24, 2026 09:25AM Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Aug 21, 2026 04:55PM
Aug 19, 2026 04:32PM
Aug 17, 2026 11:53AM
Aug 14, 2026 03:43PM
Aug 14, 2026 01:13PM
Aug 13, 2026 04:05PM
Aug 13, 2026 03:41PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 10, 2026 01:44PM
Aug 7, 2026 02:43PM
Aug 3, 2026 03:04PM
Jul 31, 2026 09:00AM
Jul 30, 2026 04:32PM
Jul 30, 2026 09:30AM
Jul 30, 2026 09:30AM Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
Jul 30, 2026 02:52AM
Jul 29, 2026 10:05AM
Jul 29, 2026 10:05AM
Jul 29, 2026 07:45AM
Jul 27, 2026 02:36PM
Jul 27, 2026 12:31PM
Jul 27, 2026 11:00AM Capricor disputes FDA briefing materials ahead of deramiocel review
Jul 27, 2026 11:00AM
Jul 7, 2026 07:18AM
Jun 26, 2026 10:02AM
Jun 26, 2026 10:02AM
Jul 18, 2025 01:43PM
Jul 14, 2025 06:58AM
Jul 3, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 02:13AM
Jun 24, 2025 12:29PM
Jun 24, 2025 10:44AM
Jun 24, 2025 09:01AM Capricor Therapeutics (CAPR) Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Jun 24, 2025 09:00AM
Jun 23, 2025 06:43AM
Jun 18, 2025 12:30PM
Jun 16, 2025 06:39AM
Jun 15, 2025 10:00AM
Jun 13, 2025 11:28AM
Jun 11, 2025 09:25AM Capricor Therapeutics (CAPR) Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
Jun 11, 2025 09:25AM

15,976 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All